Article

Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker

2020-06-02

Abstract excerpt

<h4>Background and Aims</h4> A subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. We hypothesized that chemotherapy-resistant PDACs express a glycan biomarker called sTRA. <h4>Methods: </h4> . We tested this marker to identify treatment-resistant PDAC in multiple systems: sets of cell lines,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5b5e73db-c370-5862-8d59-7e253f0c39d9
DOI: 10.1101/2020.06.01.128082

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan BiomarkerDOI 10.1101/2020.06.01.128082Read

Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotypeSemantic proximity Read

Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNASemantic proximity Read

Multidrug resistance genes screening of pancreatic cancer based on sensitivity profile to chemotherapeutic drugsSemantic proximity Read

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkersSemantic proximity Read

The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer CellsSemantic proximity Read

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugsSemantic proximity Read

A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patientsSemantic proximity Read

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancerSemantic proximity Read

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9Semantic proximity Read

ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancerSemantic proximity Read

Quantitative Serum Glycomics of Esophageal Adenocarcinoma and Other Esophageal Disease OnsetsSemantic proximity Read

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.Semantic proximity Read